Tylenol's parent company, Kenvue, saw its stock price rebound in premarket trading on Tuesday after U.S. President Donald Trump made unfounded claims about the drug.
from : World https://ift.tt/uOf13Mc
Stock in Tylenol’s parent company rallies after Trump’s unproven claims
By -
September 23, 2025
0
